Analyst Recommendations

Barclays analyst issues OVERWEIGHT recommendation for ARGX on January 6, 2026 06:33PM ET. The previous analyst recommendation was Overweight.ARGX was trading at $805.57 at issue of the analyst...

January 6, 2026   ARGX -1.23%

Barclays analyst issues OVERWEIGHT recommendation for GMAB on January 6, 2026 06:37PM ET. The previous analyst recommendation was Overweight.GMAB was trading at $33.0601 at issue of the analyst...

January 6, 2026   GMAB 1.39%

Barclays analyst issues OVERWEIGHT recommendation for AZN on January 6, 2026 06:35PM ET. The previous analyst recommendation was Overweight.AZN was trading at $94.42 at issue of the analyst...

January 6, 2026   AZN 0.39%

Morgan Stanley analyst issues OVERWEIGHT recommendation for MT on January 6, 2026 05:26PM ET. The previous analyst recommendation was Overweight.MT was trading at $47.925 at issue of the...

January 6, 2026   MT -0.18%

Barclays analyst issues UNDERWEIGHT recommendation for GSK on January 6, 2026 04:50PM ET. The previous analyst recommendation was Equal-Weight.GSK was trading at $50.52 at issue of the analyst...

January 6, 2026   GSK 0.60%

Jefferies analyst issues BUY recommendation for TEVA on January 6, 2026 12:37PM ET. The previous analyst recommendation was Buy.TEVA was trading at $31 at issue of the analyst...

January 6, 2026   TEVA -0.06%

Morgan Stanley analyst issues OVERWEIGHT recommendation for BLTE on January 6, 2026 10:00AM ET. BLTE was trading at $159.42 at issue of the analyst recommendation.The overall analyst consensus...

January 6, 2026   BLTE 1.69%

Morgan Stanley analyst issues OVERWEIGHT recommendation for RTO on January 6, 2026 09:37AM ET. RTO was trading at $30.15 at issue of the analyst recommendation.The overall analyst consensus...

January 6, 2026   RTO 0.48%

RBC Capital analyst issues OUTPERFORM recommendation for DEO on January 6, 2026 09:44AM ET. The previous analyst recommendation was Sector Perform.DEO was trading at $89.55 at issue of...

January 6, 2026   DEO -0.83%

Bradesco analyst issues NEUTRAL recommendation for PAC on January 5, 2026 10:15PM ET. The previous analyst recommendation was Outperform.PAC was trading at $262.45 at issue of the analyst...

January 5, 2026   PAC -0.37%